FOLLOW-UP PERIOD

FOLLOW-UP PERIOD: A Procedural Biotech Thriller

The treatment worked. It gave dying patients years they were never supposed to have.

Then the follow-up period ended.

A decade later, scattered neurological deaths begin to disturb the silence left behind by one of oncology’s most celebrated experimental treatments. The official record says there is no pattern. No signal. No causal link established.

Mara Tallis, a medical safety reviewer trained to trust evidence rather than intuition, is asked to examine what the system insists does not yet exist. The cases are incomplete. Biological material is missing. The survivors are real. Current patients still need access. And every responsible attempt to investigate threatens to harm the very people the treatment once saved.

As Mara follows the question through closed archives, survivor registries, corporate access programs, missing tissue, public panic, regulatory language, and infrastructure that remembers containers better than patients, she confronts a problem no protocol was designed to solve:

What if evidence disappeared not because anyone destroyed it, but because the system stopped looking before the question could appear?

FOLLOW-UP PERIOD is a slow-burn procedural biotech thriller about medicine, uncertainty, institutional responsibility, and the quiet violence of conclusions reached too early.

There is no easy villain, no clean conspiracy, and no comforting final answer. Its tension lives in evidence, consent, missing material, patient access, public language, and the dangerous space between “not proven” and “not there.”

For readers drawn to intelligent medical thrillers, institutional suspense, near-future biotech, and morally difficult fiction about systems that are not evil, but correct within the limits they were built to see.

The causal link remains unestablished.

The question does not.